INMB
INmune Bio Inc
2.20$
-5.7%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +89.7% | -6.3% | -100.0% | – | |
| – | – | – | +4,911.8% | -59.0% | -24.0% | +54.1% | +49.1% | +3.1% | +3.2% | +30.3% | |
| – | -58.3% | -0.9% | +20,081.9% | -59.0% | -24.0% | +54.1% | +49.1% | – | – | – | |
| – | -12,085.1% | – | +1,789.3% | -168.7% | – | -7,192.8% | – | – | -90.1% | -344.1% | |
| – | – | – | -100.0% | – | – | +374,999,900.0% | -100.0% | – | – | – | |
| – | +0.0% | +0.0% | +14,900.0% | +0.0% | +0.0% | +0.0% | – | – | – | – | |
| – | +233.3% | +1,956.0% | -56.2% | +1,256.6% | -108.3% | – | -100.0% | – | – | – | |
| – | +0.0% | – | – | +0.0% | +0.0% | +0.0% | -100.0% | – | +100.0% | -100.0% | |
| – | +1,400.0% | +356.9% | -56.2% | +1,256.6% | +95.7% | +303.2% | -99.2% | -679.6% | – | +51.6% | |
| – | +992.2% | +847.0% | -196.4% | – | +119.9% | +253.0% | -142.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.